Nobuaki Mamesaya Selected Research

Nobuaki Mamesaya Research Topics

Disease

24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 12/2017
21	Neoplasms (Cancer) 05/2024 - 07/2017
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 04/2018
6	Pneumonia (Pneumonitis) 02/2023 - 05/2017
5	Neoplasm Metastasis (Metastasis) 12/2021 - 04/2018
4	Cachexia 05/2024 - 06/2020
4	Lung Neoplasms (Lung Cancer) 09/2022 - 06/2017
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2022
2	Disease Progression 03/2024 - 01/2023
2	Febrile Neutropenia 12/2023 - 06/2017
2	Radiation Pneumonitis 03/2023 - 03/2021
2	Adenocarcinoma of Lung 07/2017 - 01/2017
1	Weight Gain 05/2024
1	Body Weight (Weight, Body) 05/2024
1	Type 2 Diabetes Mellitus (MODY) 05/2024
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2024
1	Glioma (Gliomas) 03/2024
1	Thyroid Neoplasms (Thyroid Cancer) 03/2024
1	Carcinoma (Carcinomatosis) 01/2024
1	Weight Loss (Weight Reduction) 02/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Microsatellite Instability 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Hemorrhage 01/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2017
1	Neutropenia 06/2017
1	Heart Failure 05/2017
1	Aspiration Pneumonia 05/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Dyspnea (Shortness of Breath) 01/2017
1	Fever (Fevers) 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 09/2012

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
7	durvalumabIBA 03/2024 - 10/2020
7	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2017
6	B7-H1 AntigenIBA 04/2024 - 05/2020
5	Tyrosine Kinase InhibitorsIBA 12/2021 - 01/2019
4	osimertinibIBA 11/2021 - 01/2017
3	NivolumabIBA 02/2023 - 12/2017
3	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 06/2017
3	pembrolizumabIBA 01/2022 - 05/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2017
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2021
2	amrubicinIBA 12/2023 - 11/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 06/2017
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 06/2017
2	LigandsIBA 01/2023 - 04/2021
2	Angiogenesis InhibitorsIBA 01/2022 - 11/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2019
2	PlatinumIBA 11/2019 - 06/2017
1	Glucose (Dextrose)FDA LinkGeneric 05/2024
1	Hemoglobins (Hemoglobin)IBA 05/2024
1	anamorelinIBA 05/2024
1	Ghrelin ReceptorsIBA 05/2024
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	trametinibIBA 03/2024
1	dabrafenibIBA 03/2024
1	pegfilgrastim (Neulasta)FDA Link 12/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Surface Antigens (Surface Antigen)IBA 09/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	RamucirumabIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 07/2017
1	alectinibIBA 07/2017
1	Serum AlbuminIBA 05/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2012
1	Itraconazole (Sporanox)FDA LinkGeneric 09/2012
1	Voriconazole (Vfend)FDA LinkGeneric 09/2012
1	Micafungin (FK463)FDA Link 09/2012

Therapy/Procedure

15	Therapeutics 01/2024 - 09/2012
12	Drug Therapy (Chemotherapy) 01/2024 - 06/2017
7	Chemoradiotherapy 03/2024 - 04/2018
6	Radiotherapy 03/2023 - 06/2017
5	Aftercare (After-Treatment) 11/2021 - 01/2017
3	Immunotherapy 01/2022 - 01/2021
2	Precision Medicine 05/2022 - 01/2022
1	Adjuvant Chemotherapy 04/2024
1	Genomic Medicine 12/2022
1	Retreatment 06/2022
1	Cranial Irradiation 04/2018
1	Gastrostomy 05/2017
1	Length of Stay 05/2017